FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Dan: Q1 Ahead Of Expectations; Maintains 2026 Guidance

By

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Dana Incorporated (DAN) posted Q1 adjusted EBITDA of $171M vs. $93M (+84%), ahead of the $160M consensus. Revenue rose 5% to $1.87B ($40M ahead of consensus) and adjusted EBITDA margin expanded 400 bps to 9.2% (40 bps above consensus). DAN's Q1 adjusted EBITDA margin expansion was due to cost savings and efficiency improvements. Management said it realized $35M in additional cost savings during Q1. DAN reaffirmed its prior 2026 guidance, and management said the Dana 2030 plan outlines a clear path to higher sales, structurally higher margins, and increased adjusted free cash flow generation. DAN said it repurchased 4.4M shares for $125M in Q1. The company also currently pays a $0.48/share annualized dividend. DAN's shares were little changed following the release. DAN was the best-performing stock in the auto supplier space by a wide margin in 2025 (+110% vs. +16% for the S&P 500), and we consider management's significant margin improvement progress and aggressive share repurchases as positives.

Related Articles

US Markets

Fed Chair Nominee Kevin Warsh Wins Senate Banking Committee Vote

The US Senate Banking Committee voted Wednesday to advance Kevin Warsh's nomination as Federal Reserve chair to the Republican-controlled Senate.Warsh is President Donald Trump's pick to replace Jerome Powell, whose term as Fed chief expires on May 15. Trump has repeatedly criticized Powell for the central bank's cautious view on lowering interest rates.The committee voted 13-11 to set Warsh up for a final confirmation vote in the Senate, hours before the Fed was scheduled to announce its decision on interest rates. The Federal Open Market Committee is widely expected to leave its policy rate unchanged later today.This could be Powell's last monetary policy meeting as Fed chief, assuming the full Senate confirms Warsh in the week of May 11.Powell's term on the Fed's Board of Governors runs through January 2028, though its unclear if he would exit the Fed or decide to stay on."If the Senate Banking Committee confirms Kevin Warsh tomorrow morning, Powell could potentially announce he is stepping down at the press conference, with Warsh presumably taking a seat at the helm for the June FOMC meeting," Stifel said in a note on Tuesday.Warsh served as a governor on the central bank's board from 2006 to 2011. Before joining the Fed, he was part of the George W. Bush White House and had worked at Morgan Stanley (MS).

Research

Research Alert: CFRA Trims View On Shares Of Coca-cola Europacific Partners To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price for Coca-Cola Europacific Partners (CCEP) to USD88 from USD109. This is based on a 2026 P/E of 17.5x, below its five-year historical average of 18.2x and the industry forward average of 18.2x. We believe our relative valuation appropriately reflects CCEP's waning growth potential (to a typical 3%-4% annual growth) and limited room for organic margin expansion under the current operating environment. We revise our 2026 EPS to EUR4.29 from EUR4.50 and 2027 EPS to EUR4.32 from EUR4.70. We think CCEP faces structural margin headwinds from heavy Coa-Cola branding dependence and incidence pricing constraints. While CCEP is seen mitigating this through mix shift toward Monster Energy, we expect volume to normalize through 2026. We believe management's 2026 cost guidance (c.1.5%) is optimistic given potentially underestimating the incidence rates and likely overestimated productivity benefits, especially in a cost-sensitive environment.

$CCEP
Research

Research Alert: Amphenol Reports Strong Q1 2026 Results, Supported By Ai Demand

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Amphenol delivered record Q1 2026 results with sales of $7.6B (+58% Y/Y, +33% organic) and adjusted EPS of $1.06 (+68% Y/Y), both exceeding the high end of guidance. Record orders of $9.4B resulted in a robust 1.24:1 book-to-bill ratio, indicating strong underlying demand momentum across the diversified portfolio. Communications Solutions continued as the primary growth engine, generating sales of $4.5B (+88% Y/Y) with 30.6% operating margins, now representing 60% of total revenue. Q2 guidance suggests continued momentum with sales expected at $8.1B-$8.2B (+43%-45% Y/Y) and adjusted EPS of $1.14-$1.16 (+41%-43% Y/Y). We believe the company's transformation into a dominant AI infrastructure player is progressing well, with adjusted operating margins reaching 27.3% (+380 bps Y/Y) demonstrating strong operational leverage. We expect the CommScope CCS acquisition to generate sustained growth, contributing approximately $900M in Q1 sales, while monitoring the pro forma net leverage of 1.8x.

$APH